Patrick Griffin

Dr. Griffin has served more than 25 years in clinical development, having been responsible for 11 FDA drug approvals and 40 IND’s, all within obesity and gastroenterology. Dr. Griffin co-founded Incregen Therapeutics, Inc and serves as chief executive officer. Prior to Incregen, he was chief medical officer of 9Meters Biopharma from February 2019 through April 2023 and prior to that Chief Medical Officer of Innovate Biopharmaceuticals.

Previously, Dr. Griffin served at Synergy Pharmaceutics from May 2013 through November 2018, ending as executive vice president and chief medical officer. From March 2012 to April 2013, he served as chief medical officer and senior vice president of development at ImmusanT, Inc. Dr. Griffin served as associate vice president, clinical development and head of external innovation at Sanofi-Aventis (now Sanofi) from March 2009 until January 2012. He is a board-certified physician in both internal medicine and gastroenterology, and is a

Fellow of the American College of Physicians. Dr. Griffin received his medical degree from Columbia University, completing a residency in internal medicine at Presbyterian Hospital in New York, and a fellowship in gastroenterology at Brigham and Women’s Hospital in Boston. Following his residency and fellowship, Dr. Griffin joined the medical faculty of Columbia College of Physicians and Surgeons, where he held a number of academic, clinical research, teaching and management positions, and a private practice in New York.